Please login to the form below

SOCIAL MEDIA: A HEALTH HAZARD? — The case to embrace going social

It’s no surprise: compared with the digital progress of healthcare, social media area recklessly fast-moving phenomena. They do not wait for regulations. There are no trials. Facebook, for an obvious example, launched in 2004, topped 5.5 million users at the end of 2005, and then hit 500 million around mid-2010. In the time it would take a medical researcher to get some solid clinical results, Facebook’s appearance, advertising policy, and privacy policy have changed countless times to accommodate its evolving business model.

3rd January 2014

Share

Tags

Company Details

HAVAS LYNX

+44 (0)161 228 7756

Contact Website

Address:
52 Princess Street
Manchester
M1 6JX

Latest content on this profile

Trio of Communiqué Awards for Havas Lynx
A global healthcare communications agency, with offices in Manchester, London and New York, is celebrating again after collecting a trio of titles at the Communiqué Awards.
HAVAS LYNX
Havas Lynx Scoops Healthcare Agency of the Year at Cannes Lions 2018
Global healthcare communications agency, Havas Lynx, celebrated winning top honours as they collected three prestigious Cannes Lions awards alongside the highly coveted Cannes Lions Healthcare Agency of the Year 2018.
HAVAS LYNX
SWITCHED ONcology Patient Experience Focus Group Full Discussion
On 22nd February we held our patient experience focus group, which brought together patients, doctors and industry advocates to discuss the changing landscape and challenges facing cancer care today. In the patient experience focus group, the discussion focused on the patient journey from pre-diagnosis right through to treatment and support. The focus group provided deeper insight in to a number of themes including the transformation of cancer understanding, the barriers to cancer diagnosis, the advent of new treatments including immunotherapy, communication around treatment, access to information for both patients and hcps, patient support & wellbeing and the role of caregivers.
HAVAS LYNX
SWITCHED ONcology Patient Experience Focus Group Highlights
On 22nd February we held our patient experience focus group, which brought together patients, doctors and industry advocates to discuss the changing landscape and challenges facing cancer care today. "We are at a time of fundamental change in our understanding around the disease - the way we access it, categorise it and the way we think about it. Has the language kept up? That's the question that I have." Vernon Bainton, Chief Medical Officer, Havas Lynx Group
HAVAS LYNX
SWITCHED ONcology
We bring together the experts. The patients. The scientists. The technologists. The creatives. We unite powerful insights to make science mean something real. We are stronger together. We are Switched ON. Switched ONcology is the latest thought leadership campaign from the award-winning Havas lynx portfolio. The campaign is designed to combine science, creativity and technology in the delivery of communications that better support healthcare professionals, carers and ultimately patients on their journey with cancer. The campaign provides our partners with deeper insight, smarter ideas and more meaningful innovations, born out of an unprecedented investment into oncology.
HAVAS LYNX
The Big Communication - matching unprecedented clinical advances in immunotherapy with transformative communication
In this white paper, we explore the exciting new frontier of cancer treatment - immuno-oncology (IO) - and what it means for how we communicate with healthcare professionals, patients and carers. For those on the frontline of treating cancer, IO brings a whole new level of excitement and opportunity, but also unprecedented complexity and uncertainty. And for patients, the practicalities of cancer treatment have changed. In short, the fundamental realities of cancer has changed and communication has never had a more important a role to play.
HAVAS LYNX